Clinical trial NCT07014774: Efficacy of Laser Acupuncture on Carpal Tunnel Syndrome Following Hand Flexor Tendon Repair
Official title: Efficacy of Laser Acupuncture on Carpal Tunnel Syndrome Following Hand Flexor Tendon Repair
Study type: INTERVENTIONAL
Overall status: NOT_YET_RECRUITING
Phase: NA
Conditions: Laser Acupuncture
Flexor Tendon Repair
Hand Surgery
Carpal Tunnel Syndrome (CTS)
Lead sponsor: Cairo University
Sponsor class: OTHER
First posted: 2025-06-11
Enrollment: 60
Sex: ALL
Minimum age (years): 20
Maximum age (years): 40
Standard ages: ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: The purpose of this study is to determine the efficacy of laser acupuncture in alleviating CTS symptoms following flexor tendon repair in the hand.

Detailed description: This study holds significant importance for clinical practice, patient care, and research.

* Clinical Practice: It provides a potential framework for physical therapists to design targeted and effective interventions for laser acupuncture on CTS following flexor tendon repair in the hand.
* Patient Care: Improved rehabilitation outcomes can enhance patients' physical functionality, independence, and overall quality of life, addressing a critical gap in post-operative complications.
* Research Advancement: By contributing to the limited body of literature on laser acupuncture in this context, the study can stimulate further research and innovation in carpal tunnel syndrome following hand flexor tendon repair.

Eligibility criteria: Inclusion Criteria:

* Adults aged 20-40 years who have undergone flexor tendon repair surgery.
* Patients who have undergone primary or secondary repair of flexor tendons in the hand at zone 4 (zone of carpal tunnel as it often be complicated by postoperative adhesions due to close quarters and synovial sheath of the carpal tunnel) (Fulchignoni C et al., 2020).
* Surgery occurred within a specific timeframe, often within 6-12 weeks prior to inclusion (Peters SE, Jha B, Ross M., 2021).
* Patient have clinical and electro diagnostic evidence of CTS.
* All patients enrolled to the study will have their informed consent.

Exclusion Criteria:

* Pre-existing neurological disorders.
* Systemic illnesses affecting nerve function (e.g., diabetes).
* Contraindications to laser therapy.
* Pregnancy or breastfeeding.
* Active infections or open wounds in the hand or wrist.
* Previous history of carpal tunnel release surgery or received an injection of steroid for CTS.
* Previous history of brachial plexus injury or median nerve injury.
* Other severe neurological or musculoskeletal conditions.
* Epilepsy or any psychological disorders.
* Cancer.
* Spots over the treated points.
* Pacemaker or implanted devices.

Primary outcomes:
measure: Symptom Relief:
timeFrame: At baseline and after 8 weeks
Secondary outcomes:
measure: - Grip Strength:
timeFrame: Measured at baseline and at the end of the intervention (8 weeks).
measure: - Nerve Conduction Velocity (NCV):
timeFrame: baseline and 8 weeks.
Other outcomes:
Locations:
city: Cairo
country: Egypt
facility: Learning Hospitals Al Kaser Al Ayni Hospitals
Study officials:
References: